Bumetanide .25 mg/mL

Bumetanide .25 mg/mL is a loop diuretic injection used for fluid retention and edema management. This Hikma Pharmaceuticals product is available in 10 mL vials, suitable for intramuscular or intravenous administration.

Bumetanide .25 mg/mL is commonly used to reduce excess fluid in the body, often associated with conditions like edema or heart failure. It works by promoting urine production, helping to alleviate swelling and discomfort. This medication is typically administered when oral diuretics are not feasible or effective.

Bumetanide .25 mg/mL may cause increased urination, which is its primary effect. Some users might experience dizziness, dehydration, or electrolyte imbalances. It is important to stay hydrated and monitor for any unusual symptoms while using this medication.

Bumetanide .25 mg/mL should be used with caution in individuals with kidney or liver issues. It is essential to follow healthcare provider instructions regarding administration and monitoring. Keep the vials stored properly and out of reach of children.

Bumetanide .25 mg/mL may interact with other medications, including NSAIDs, ACE inhibitors, and certain antibiotics. Alcohol consumption should be avoided as it can exacerbate side effects. Always inform healthcare providers about all medications being taken.